QTTB
Q32 Bio Inc.
Key Financials
Net Income
$29.8M
↑ 162.5%
Revenue
$53.7M
↑ Infinity%
Operating Income
$16.9M
↑ 125.6%
Total Assets
$61.8M
↓ 33.1%
EPS (Diluted)
$2.42
↑ 136.8%
Total Liabilities
$19.8M
↓ 77.2%
Shareholders' Equity
$42.0M
↑ 640.3%
Cash & Equivalents
$48.3M
↓ 38.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| 10-Q | 8/5/2026 | View on SEC |
| 8-K | 8/5/2026 | View on SEC |
| SCHEDULE 13G/A | 7/31/2026 | View on SEC |
| EFFECT | 7/28/2026 | View on SEC |
| 424B3 | 7/28/2026 | View on SEC |
| 4/A | 7/21/2026 | View on SEC |
| 4/A | 7/21/2026 | View on SEC |
| 4/A | 7/21/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | QTTB |
| Company Name | Q32 Bio Inc. |
| CIK | 1661998 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 781-999-0232 |